News | May 28, 2015

Leksell Gamma Knife Icon to Benefit More Patients with Brain Disease

Latest iteration features advanced motion management, dose delivery

May 28, 2015 — With the introduction of Elekta's new Leksell Gamma Knife Icon, the benefits of precision cranial radiosurgery are now available for more patients with a wider variety of tumor types and sizes. This latest generation stereotactic radiosurgery system for the brain integrates advanced motion management, dose delivery and imaging technologies, significantly increasing the versatility of Gamma Knife radiosurgery. Elekta unveiled Leksell Gamma Knife Icon at the 3rd European Society for Therapeutic Radiology and Oncology (ESTRO) Forum in Barcelona.

Icon provides increased flexibility by allowing physicians to choose either frame-based or frameless methods to immobilize the patient's head, in addition to the option to perform the treatment in a single session or multiple sessions (fractions or hypofractionation). The system even enables clinicians to choose the degree of precision needed for each patient's case – ranging from traditional radiosurgery accuracy to ultra-precise microradiosurgery.

"With Leksell Gamma Knife Icon, we expect two major changes," said Prof. Jean Regis, a neurosurgeon and Gamma Knife program director at University Hospital La Timone (Marseilles, France). "First, the system will increase indications, in the sense that we will be able do more hypofractionation. The second great benefit of Icon is the ability to do true adaptive radiosurgery both interfraction and intrafraction. It has the capacity to detect and measure position changes – to automatically propose dose planning adaptation – while providing the operator with an estimate of the influence of these corrections for validation."

Elekta developed Icon to be the preferred modality to treat almost any intracranial target. It offers new functionality familiar to radiation oncologists, such as cone beam computed tomography (CBCT), which should help increase the adoption of radiosurgery.

Leksell Gamma Knife Icon is not for sale or distribution in the U.S. and is not CE marked.

For more information: www.elekta.com

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init